Aikido Provides Update on Use of Machine Learning in Drug Development Program
FOR IMMEDIATE RELEASE: Aikido Provides Update on Use of Machine Learning in Drug Development Program NEW YORK, NY August , 2021 /PRNewswire/ AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today provided and update on the use of Machine Learning in support of its antiviral platform with the University of Maryland Baltimore School of […]
Job Opening: Scientific Programmer
SilcsBio’s parent company, Early Charm, has a job opening to work with SilcsBio and other companies in its Drug Design Portfolio. Immediate Job Opening Scientific Programmer July 27, 2021 What we do: Early Charm creates, owns, and operates businesses that convert science into revenue. We are the management team, the operators, […]
Job Opening: Machine Learning, Deep Tech Applications
SilcsBio’s parent company, Early Charm, has a job opening to work with SilcsBio and other portfolio companies focused on Drug Design and Machine Vision. Immediate Job Opening Machine Learning Deep Tech Applications July 27, 2021 What we do: Early Charm creates, owns, and operates businesses that convert science into revenue. We […]
Job Opening: Full-Stack Developer, Deep Tech Applications
SilcsBio’s parent company, Early Charm, has a job opening to work with SilcsBio and other portfolio companies focused on Drug Design and Machine Vision. Immediate Job Opening Full-Stack Developer Deep Tech Applications July 27, 2021 What we do: Early Charm creates, owns, and operates businesses that convert science into revenue. We […]
SilcsBio is Selected by the NIH to 2021 BIO Digital’s Innovation Zone, June 10-11 and 14-18
FOR IMMEDIATE RELEASE: SilcsBio is Selected by the NIH to 2021 BIO Digital’s Innovation Zone, June 10-11 and 14-18 SilcsBio’s Sunhwan Jo to attend BIO Digital with focus on SilcsBio’s expertise in fragment-based drug design, MD simulations, and computational drug discovery June 8, 2021, Baltimore, MD – SilcsBio, a technology company that develops […]
SilcsBio Joins with NIST and Pharma Partner In Validating SILCS Technology for Biologics Formulation
FOR IMMEDIATE RELEASE: SilcsBio Joins with NIST and Pharma Partner In Validating SILCS Technology for Biologics Formulation Scientific collaboration demonstrates effective computational method for stabilizing biologic therapeutics such as antibodies December 16, 2020, Baltimore, MD – SilcsBio, LLC, a technology company that develops and markets software and services for structure-based drug design, today announced members […]
SilcsBio and Dalriada Drug Discovery Launch Partnership to Create a Rapid Drug Discovery Service Suite
SilcsBio and Dalriada to tap areas of expertise in drug design and development to accelerate clients’ programs in development of therapeutic treatments against diseases with unmet needs, initiated with COVID-19 FOR IMMEDIATE RELEASE: June 11, 2020, Baltimore, MD and Toronto, ON – SilcsBio, a technology company that develops innovative software and provides services for structure-based […]